§ Funding Round
ArriVent Biopharma raised $155M Series B venture round, led by elena viboch.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
elena vibochLEAD | Angel | elena viboch |
HBM Healthcare Investments | — | — |
Hongshan Capital Group (Sequoia Capital China) | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | carl gordon | |
| Organization | — | |
| Organization | — | |
james healyLEAD | Angel | james healy |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$465M
Top Valuation
-
ArriVent Biopharma raised $155M in a Series B round.
The round was announced on 03/27/23.
The round was led by elena viboch, james healy.
